February 1982
Founded

Dennis Gillings, London-born professor at the University of North Carolina (UNC), signs his first consulting contract. His team of part-time staff working in a trailer on the UNC campus provides statistical and data management consulting for pharmaceutical customers. Quintiles is formally incorporated in North Carolina, co-founded by Dennis and Gary Koch who remains as a professor at the University of North Carolina.

January 1987
Goes Global

Quintiles begins its global expansion, opening its U.K. United Kingdom operations to serve customers in Europe. The office moves from London to Reading in 1989 and to Bracknell in 1994. In 2011, Quintiles moves back to Reading, opening its new European headquarters in Green Park.

November 1992
Adds Laboratories

Quintiles Laboratories Ltd. opens in Atlanta, Georgia, growing from one small room offering safety testing to a global network with a full-service offering, including biomarkers to esoteric evaluations. Today, it is a one-source solution for lab testing across the development spectrum, anywhere in the world.

August 1993
Asia Arrival

Quintiles establishes operations in Asia, opening in Tokyo to expand services to Japanese customers. Today, Quintiles Asia spans the continent providing Clinical, Commercial, Consulting and Capital Solutions, delivered by more than 4,000 employees in 15 countries.

April 1994
Goes Public

Quintiles goes public, completing an initial public offering of Quintiles stock.

May 1996
Adds Consulting

Quintiles establishes its Consulting practice with the acquisition of a globally recognized health care policy research and management consulting company.   Today, Quintiles helps customers move from insight to execution. Our consulting practices are Product Development & Commercialization, Market Access, Regulatory & Quality, Market Intelligence, Late Phase, IT Strategy & Implementation.

November 1996
Commercial Strength

Quintiles combines with Innovex Ltd., a U.K.-based contract pharmaceutical company specializing in sales and marketing services for major pharma companies. The addition of Innovex makes Quintiles the world's largest full-service biopharmaceutical services company and enables Quintiles to provide services across a product lifecycle.

January 1999
Growth through Partnering

Quintiles acquires Hoechst Marion Roussel's drug development facility in Kansas City and employs about 500 of its staff. In addition, Quintiles partners with HMR over five years for support of ongoing HMR projects. The group expands and in 2007, Quintiles moves to a new facility in Overland Park with a 150-bed Phase I Unit, and room for up to 200 more employees.

July 2002
Capital and Commercial Combined

Quintiles signs landmark partnership agreement with Eli Lilly and Company to commercialize Cymbalta®. Quintiles makes an initial $110 million investment and provides a dedicated primary care team comprising some 500 representatives, 50-plus managers, four regional trainers and, latterly, a national trainer based in-house. Cymbalta® exceeds all sales forecasts, topping $3 billion by year three.

April 2003
Goes Private

Quintiles becomes a private company led by founder and Chairman Dennis Gillings, CBE, PhD.

March 2009
New HQs

Quintiles moves into new world headquarters, Quintiles Plaza, in Durham, NC. Quintiles' expanded Asia-Pacific headquarters opens in November 2009 and its new European headquarters is inaugurated in the U.K. in October 2011.

November 2011
Real World Powerhouse

With late phase and observational research becoming increasingly important to multiple healthcare stakeholders, Quintiles acquires Outcome Sciences, positioning Quintiles as the industry powerhouse in late phase and real world research.